Trial Profile
Validation of Non-invasive Technologies for the Characterization of Sweat Gland Function in Patients With Recessively Inherited Hypohidrotic Ectodermal Dysplasia, Their Heterozygous Family Members and Healthy Controls
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2014
Price :
$35
*
At a glance
- Drugs DMX 101 (Primary)
- Indications Ectodermal dysplasia
- Focus Therapeutic Use
- 07 Nov 2014 New trial record